|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2009-10-19
|
|
pubmed:abstractText |
The efficacy of S-1 as part of a 2nd/3rd-line therapy in cases of advanced recurrent colon cancer was studied.
|
|
pubmed:language |
jpn
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0385-0684
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1667-70
|
|
pubmed:meshHeading |
pubmed-meshheading:19838025-Aged,
pubmed-meshheading:19838025-Antineoplastic Agents,
pubmed-meshheading:19838025-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19838025-Colonic Neoplasms,
pubmed-meshheading:19838025-Disease Progression,
pubmed-meshheading:19838025-Drug Combinations,
pubmed-meshheading:19838025-Female,
pubmed-meshheading:19838025-Humans,
pubmed-meshheading:19838025-Japan,
pubmed-meshheading:19838025-Leukopenia,
pubmed-meshheading:19838025-Male,
pubmed-meshheading:19838025-Middle Aged,
pubmed-meshheading:19838025-Neoplasm Staging,
pubmed-meshheading:19838025-Neutropenia,
pubmed-meshheading:19838025-Oxonic Acid,
pubmed-meshheading:19838025-Prognosis,
pubmed-meshheading:19838025-Recurrence,
pubmed-meshheading:19838025-Salvage Therapy,
pubmed-meshheading:19838025-Survival Rate,
pubmed-meshheading:19838025-Tegafur
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
[The efficacy of S-1 monotherapy as a 2nd/3rd-line therapy for unresectable recurrent colon cancer: Kanagawa conference of clinical oncology (KCCO)].
|
|
pubmed:affiliation |
Dept. of Surgery, Isehara Kyodo Hospital.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
